Psyllid ID: psy13157

Local Sequence Feature Prediction

Prediction and (Method)	Result

Residue Number Marker

Protein Sequence

Secondary Structure (PSIPRED)

Secondary Structure Prediction (SSPRO)

Coil and Loop (DISEMBL)

Flexible Loop (DISEMBL)

Low Complexity Region (SEG)

Disordered region (IsUnstruct)

Disordered Region (DISOPRED)

Disordered Region (DISEMBL)

Disordered Region (DISPRO)

Transmembrane Helix (TMHMM)

Transmembrane Helix (HMMTOP)

Transmembrane Helix (MEMSAT)

TM Helix, Signal Peptide (MEMSAT_SVM)

TM Helix, Signal Peptide (Phobius)

Signal Peptide (SignalP HMM Mode)

Signal Peptide (SignalP NN Mode)

Coiled Coils (COILS)

Positional Conservation

--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------1410------1420------1430----

MQTVKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIPPPPPPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVPEPVNPCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKPPEGLSPGTSVFCHSYVYG

cccccEEEEEcccccccccccccccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccEEEEcccccEEEcccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccEEEEccccccccccccccccccccccccccccccccccccEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEcccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEcccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccEEEccccccEEcccccccccccccccccccccccccccccccccccc

ccEEEEEEEEEEEEEccccHHHcccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEcccccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEEccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccEccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccEEEccccccEEEccccccccccccccccccccccccccccccccccc

MQTVKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVinhtpictcpqgyvgdafsgcypkppehpcpgscgqnancrvinhspvcsckpgftgeprircnkiphgvcvclpdyygdgyvscrpecvlnsdcpsnkacirnkcknpcvpgtcgegaicnvenhavmctcppgttgspfiqckpvqnepvytnpcqpspcgpnsqcreinsqavcsclpnyfgsppacrpectvnsdclqskacfnqkcvdpcpgtcgqnancrvinhspictckpgftgdalvycnrippsrplesppeyvnpcvpspcgpyaqcrdingspscsclpnyigappncrpecvqnsecphdkacinekcadpclgscgygavctvinhspictcpegfigdafsscypkppepiepviqedtcncvpnaecrdgvclclpdyygdgyvscrpecvqnsdcprnkacirnkcknpctpgtcgegaicdvvnhavsctcppgttgspfvqcktiqyepvytnpcqpspcgpnsqcrevnhqavcsclpnyfgsppacrpectvnsdcpldkacvnqkcvdpcpgscgqnancrvinhspvcsckpgftgeprircnkipprpppqedvpepvnpcypspcgpysqcrdiggspscsclpnyigsppncrpecvmnsecpsheasrpppqedvpepvnpcypspcgpysqcrdiggspscsclpnyigsppncrpecvmnsecpsheacinekcqdpcpgscgynaeckvinhtpictcpqgfigdafsgcypkppepeqpviqedtcncvpnaecrdgtflaeqpviqedtcncvpnaecrdgvcvclpdyygdgyvscrpecvlnndcpsnkacirnkcknpcvpgtcgqgavcdvinhavmctcppgttgspfvqckpiqnepvytnpcqpspcgpnsqcrevnkqapvytnpcqpspcgpnsqcrevnkqsvcsclpnyfgsppacrpectvnsdcpldkacvnqkcvdpcpgscgqnancrvinhspvcsckpgftgeprircnrihavmctcppgttgspfvqckpiqnepvytnpcqpspcgpnsqcrevnkqavcsclpnyfgsppacrpectvnsdcplnkacqnqkcvdpcpgtcgqnanckvinhspictckpgytgdalsycnrippppppqepictckpgytgdalsycnrippppppqddvpepvnpcypspcglysecrnvngapscsclinyigsppncrpeciqNSLLLGQSLLrthsavqpviqedtcncvpnaecrdgvcvclpdyygdgyvscrpecvlnndcprnkacikykcknpcvsavqpviqedtcncvpnaecrdgvcvclpeyygdgyvscrpecvlnndcprnkacikykcknpcvhpicscpqgyigdgfngcypkppeglspgtsvfchsyvyg

MQTVKFRIIIRsviasldtlgiLGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIPPPPPPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVPEPVNPCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKPpeglspgtsvFCHSYVYG

MQTVKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIpprpppqedvpepvnpCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIppppppQEPICTCKPGYTGDALSYCNRIppppppqddvpepvnpCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKPPEGLSPGTSVFCHSYVYG

***VKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTN************CREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIP**********YVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRI****************************PYSQCRDIGGSPSCSCLPNYIG****************************************CGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYP********VIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVY********************************************KQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTN************CREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYC*************CTCKPGYTGDALSY********************CYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKP*****PGTSVFCHSYV**

*QTVKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIPPPPPPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVPEPVNPCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKPPEGLSPGTSVFCH***Y*

MQTVKFRIIIRSVIASLDTLGILGSTVTKYLLEKLITACRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNS*****************EPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFLAEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCKNPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIPPPPPPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVPEPVNPCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQEDTCNCVPNAECRDGVCVCLPEYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVHPICSCPQGYIGDGFNGCYPKPPEGLSPGTSVFCHSYVYG

oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

iiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii

SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Alignment graph	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query		1434	2.2.26 [Sep-21-2011]
Q01705		2531	Neurogenic locus notch ho	yes	N/A	0.679	0.384	0.240	2e-19
P46530		2437	Neurogenic locus notch ho	no	N/A	0.668	0.393	0.243	3e-18
Q07008		2531	Neurogenic locus notch ho	yes	N/A	0.671	0.380	0.239	8e-18
P46531		2555	Neurogenic locus notch ho	no	N/A	0.539	0.302	0.237	8e-17
Q04721		2471	Neurogenic locus notch ho	no	N/A	0.578	0.335	0.238	2e-16
Q9UM47		2321	Neurogenic locus notch ho	no	N/A	0.589	0.364	0.246	1e-15
P07207		2703	Neurogenic locus Notch pr	no	N/A	0.472	0.250	0.251	1e-14
P21783		2524	Neurogenic locus notch pr	N/A	N/A	0.351	0.199	0.256	3e-14
Q9R172		2319	Neurogenic locus notch ho	no	N/A	0.594	0.367	0.238	8e-13
Q5ZQU0		1403	Sushi, nidogen and EGF-li	no	N/A	0.305	0.312	0.247	1e-12

>sp\|Q01705\|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus GN=Notch1 PE=1 SV=3	Back alignment and function desciption

 Score = 99.4 bits (246), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 327/1357 (24%), Positives = 450/1357 (33%), Gaps = 383/1357 (28%)

Query: 73   GSCGQNANCRVINHSPVCSCKPGFTGEP--------------RIRCNKIPHG-----VCV 113
            G+C     C V N +  C C   F G+                  C+ + HG      C 
Sbjct: 29   GTCLNGGRCEVANGTEACVCSGAFVGQRCQDSNPCLSTPCKNAGTCHVVDHGGTVDYACS 88

Query: 114  CLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTC 173
            C   + G       P C+     P + AC+ N C+N    GTC    +   +     C C
Sbjct: 89   CPLGFSG-------PLCLT----PLDNACLANPCRNG---GTCDLLTLTEYK-----CRC 129

Query: 174  PPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREINSQAVCSCLPNYFGSPPACRP 233
            PPG +G    Q           +PC  +PC    QC    S  +C C P + G  P CR 
Sbjct: 130  PPGWSGKSCQQ----------ADPCASNPCANGGQCLPFESSYICRCPPGFHG--PTCRQ 177

Query: 234  ---ECTVN-SDCLQSKACFNQKCVDPC-------------------PGTCGQNANCR-VI 269
               EC+ N   C     C N+     C                   P  C     CR   
Sbjct: 178  DVNECSQNPGLCRHGGTCHNEIGSYRCACRATHTGPHCELPYVPCSPSPCQNGGTCRPTG 237

Query: 270  NHSPICTCKPGFTG----------------------DAL-VYCNRIPPSRPLESPPEYVN 306
            + +  C C PGF G                      D +  Y  R PP    +   E V+
Sbjct: 238  DTTHECACLPGFAGQNCEENVDDCPGNNCKNGGACVDGVNTYNCRCPPEWTGQYCTEDVD 297

Query: 307  PC--VPSPCGPYAQCRDINGSPSCSCLPNYIGAP-----PNC-RPECVQNS--------- 349
             C  +P+ C     C + +G  +C C+  + G        +C    C Q +         
Sbjct: 298  ECQLMPNACQNGGTCHNTHGGYNCVCVNGWTGEDCSENIDDCASAACFQGATCHDRVASF 357

Query: 350  --ECPHDKACINEKCADPCLGS-CGYGAVCTV--INHSPICTCPEGFIGDAFSSCYPKPP 404
              ECPH +  +     D C+ + C  G+ C    +N   ICTCP G+ G A S    +  
Sbjct: 358  YCECPHGRTGLLCHLNDACISNPCNEGSNCDTNPVNGKAICTCPSGYTGPACSQDVDECA 417

Query: 405  EPIEPVIQEDTC-NCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNK 463
                P      C N + + EC+     CL  Y G       P C  + +      CI N 
Sbjct: 418  LGANPCEHAGKCLNTLGSFECQ-----CLQGYTG-------PRCEIDVN-----ECISNP 460

Query: 464  CKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPN 523
            C+N          A C        C C PG  G   V C+      + T+ C  SPC  N
Sbjct: 461  CQND---------ATCLDQIGEFQCICMPGYEG---VYCE------INTDECASSPCLHN 502

Query: 524  SQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGS-CGQNAN 582
              C +  ++  C C   + G              C  D        VD C  + C   A 
Sbjct: 503  GHCMDKINEFQCQCPKGFNGHL------------CQYD--------VDECASTPCKNGAK 542

Query: 583  CRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGG 642
            C    ++  C C  G+TG     C         + D+ E    C P PC  Y  C+D   
Sbjct: 543  CLDGPNTYTCVCTEGYTG---THC---------EVDIDE----CDPDPC-HYGSCKDGVA 585

Query: 643  SPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCR 702
            + +C C P Y G        C  N                    +N C+  PC     C+
Sbjct: 586  TFTCLCQPGYTGH------HCETN--------------------INECHSQPCRHGGTCQ 619

Query: 703  DIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPG---SC--GYNAE 757
            D   S  C CL    G      P C +N +  +   C +  C D   G   +C  GY   
Sbjct: 620  DRDNSYLCLCLKGTTG------PNCEINLDDCASNPCDSGTCLDKIDGYECACEPGYTGS 673

Query: 758  CKVINHTPICTCP---QGFIGDAFSGCYPKPPEPEQP---VIQEDTCNCVP--NAECRDG 809
               +N       P    G   D  +G   + PE       + + + CN  P  +  CRDG
Sbjct: 674  MCNVNIDECAGSPCHNGGTCEDGIAGFTCRCPEGYHDPTCLSEVNECNSNPCIHGACRDG 733

Query: 810  T----------FLAEQPVIQEDTCN---CVPNAECRDG----VCVCLPDYYGDGYVSCRP 852
                       +      I  + C    CV    C+D     VC C   + G       P
Sbjct: 734  LNGYKCDCAPGWSGTNCDINNNECESNPCVNGGTCKDMTSGYVCTCREGFSG-------P 786

Query: 853  ECVLN-NDCPSNKACIRNKCKNPCVPGTCG-----QGAVCDVI----------------- 889
             C  N N+C SN    +  C +      C       GA C+V+                 
Sbjct: 787  NCQTNINECASNPCLNQGTCIDDVAGYKCNCPLPYTGATCEVVLAPCATSPCKNSGVCKE 846

Query: 890  ---NHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQ-----AP 941
                 +  C CP G  G         Q   V  N C  SPC   + C+  N         
Sbjct: 847  SEDYESFSCVCPTGWQG---------QTCEVDINECVKSPCRHGASCQNTNGSYRCLCQA 897

Query: 942  VYT--------NPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLD 993
             YT        + C+P+PC     C +    + C CLP + G+   C  +    +  P  
Sbjct: 898  GYTGRNCESDIDDCRPNPCHNGGSCTDGINTAFCDCLPGFQGA--FCEEDINECASNPCQ 955

Query: 994  KACVNQKCVDPCPGSCGQNAN-CRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGT 1052
                   CVD    +C    N     N++P C+    F G   +  + I++  C CPPG 
Sbjct: 956  NGANCTDCVDSYTCTCPVGFNGIHCENNTPDCTESSCFNGGTCV--DGINSFTCLCPPGF 1013

Query: 1053 TGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPECTV 1112
            TGS    C+   NE      C   PC     C++      C+C   Y G           
Sbjct: 1014 TGS---YCQYDVNE------CDSRPCLHGGTCQDSYGTYKCTCPQGYTG----------- 1053

Query: 1113 NSDCPLNKACQNQ-KCVDPCPGTCGQNANCKVINHSPICTCKPGYTG---DALSYCNRIP 1168
                 LN  CQN  +  D  P  C     C   N    C C+ G+TG   D LS    + 
Sbjct: 1054 -----LN--CQNLVRWCDSAP--CKNGGRCWQTNTQYHCECRSGWTGVNCDVLSVSCEVA 1104

Query: 1169 PPP-----------------PPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVPEPVNP 1211
                                   +  C C+ GYTG   SYC         +D+V E    
Sbjct: 1105 AQKRGIDVTLLCQHGGLCVDEGDKHYCHCQAGYTG---SYC---------EDEVDE---- 1148

Query: 1212 CYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRPE 1248
            C P+PC   + C +  G  SC C+  Y GS  NC  E
Sbjct: 1149 CSPNPCQNGATCTDYLGGFSCKCVAGYHGS--NCSEE 1183

Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). May play an essential role in postimplantation development, probably in some aspect of cell specification and/or differentiation. May be involved in mesoderm development, somite formation and neurogenesis. Involved in the maturation of both CD4+ and CD8+ cells in the thymus. Important for follicular differentiation and possibly cell fate selection within the follicle. During cerebellar development, functions as a receptor for neuronal DNER and is involved in the differentiation of Bergmann glia. Represses neuronal and myogenic differentiation. May enhance HIF1A function by sequestering HIF1AN away from HIF1A.
Mus musculus (taxid: 10090)

>sp\|P46530\|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio GN=notch1a PE=2 SV=1	Back alignment and function description

>sp\|Q07008\|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus GN=Notch1 PE=2 SV=2	Back alignment and function description

>sp\|P46531\|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4	Back alignment and function description

>sp\|Q04721\|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens GN=NOTCH2 PE=1 SV=3	Back alignment and function description

>sp\|Q9UM47\|NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2	Back alignment and function description

>sp\|P07207\|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster GN=N PE=1 SV=3	Back alignment and function description

>sp\|P21783\|NOTCH_XENLA Neurogenic locus notch protein homolog OS=Xenopus laevis GN=notch1 PE=1 SV=3	Back alignment and function description

>sp\|Q9R172\|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus GN=Notch3 PE=2 SV=2	Back alignment and function description

>sp\|Q5ZQU0\|SNED1_RAT Sushi, nidogen and EGF-like domain-containing protein 1 OS=Rattus norvegicus GN=Sned1 PE=2 SV=2	Back alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Alignment Graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1434
170059510		6860	dumpy [Culex quinquefasciatus] gi\|167878	0.881	0.184	0.470	0.0
270013391		21117	hypothetical protein TcasGA2_TC011986 [T	0.875	0.059	0.481	0.0
170059512		2048	conserved hypothetical protein [Culex qu	0.881	0.617	0.454	0.0
328714521		16577	PREDICTED: hypothetical protein LOC10016	0.898	0.077	0.440	0.0
442625920		18014	dumpy, isoform W [Drosophila melanogaste	0.891	0.071	0.433	0.0
442625928		19560	dumpy, isoform AA [Drosophila melanogast	0.902	0.066	0.435	0.0
442625918		20404	dumpy, isoform V [Drosophila melanogaste	0.902	0.063	0.435	0.0
442625916		21657	dumpy, isoform U [Drosophila melanogaste	0.902	0.059	0.435	0.0
442625904		22743	dumpy, isoform O [Drosophila melanogaste	0.902	0.056	0.435	0.0
442625908		22949	dumpy, isoform Q [Drosophila melanogaste	0.902	0.056	0.435	0.0

>gi\|170059510\|ref\|XP_001865394.1\| dumpy [Culex quinquefasciatus] gi\|167878260\|gb\|EDS41643.1\| dumpy [Culex quinquefasciatus]	Back alignment and taxonomy information

 Score = 1172 bits (3031), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 763/1621 (47%), Positives = 932/1621 (57%), Gaps = 357/1621 (22%)

Query: 37   TACRVINHTPICTCPQGYVGD---------------AFSGCYPKPPEHPCPGSCGQNANC 81
              CR +  +P CTC    +G                +   C  +  + PC G+CG NA C
Sbjct: 1078 AECRPVGDSPSCTCLDNMIGSPPNCRPECISNSECASNLACIRQKCQDPCTGACGANAEC 1137

Query: 82   RVINHSPVCSCKPGFTGEPRIRCNKIPH---------------------------GVCVC 114
            RV++H+P+C C  GFTG+P  +C  +                             G C C
Sbjct: 1138 RVVSHTPMCICSIGFTGDPFTQCLPVQQDVPREPSSPCTPSPCGANANCRDQNGAGSCTC 1197

Query: 115  LPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICNVENHAVMCTCP 174
            + D++G+ Y  CRPECVLNSDCPSN+AC+RNKC++PC PGTCG+ A C V NH   CTC 
Sbjct: 1198 IEDHFGNPYEGCRPECVLNSDCPSNRACVRNKCQDPC-PGTCGQNANCQVVNHLPSCTCI 1256

Query: 175  PGTTGSPFIQCKPVQNEPVYT---------------NPCQPSPCGPNSQCREINSQAVCS 219
            PG  G PF  C   Q E +Y+               NPCQP+PCGPNSQCREIN QAVCS
Sbjct: 1257 PGYEGDPFRFCNIQQREHMYSWRDPKFVYIPIQQYVNPCQPNPCGPNSQCREINGQAVCS 1316

Query: 220  CLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPICTCKP 279
            CLP Y GSPP CRPEC  +S+C   +AC NQKCVDPCPGTCG NA C V NHSPIC+C+ 
Sbjct: 1317 CLPTYIGSPPGCRPECVTSSECPLDRACVNQKCVDPCPGTCGTNARCNVNNHSPICSCQS 1376

Query: 280  GFTGDALVYCNRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPP 339
            G+TGD    C   PP  P ++     +PCVPSPCGP +QCR+ING PSCSCL NYIG+PP
Sbjct: 1377 GYTGDPFTRCYPNPPP-PQDTQVVVRDPCVPSPCGPNSQCRNINGVPSCSCLVNYIGSPP 1435

Query: 340  NCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSC 399
            NCRPEC  N+ECP ++AC+NEKC DPC GSCG GA C VINH+PICTC  G+ GD F++C
Sbjct: 1436 NCRPECTINAECPSNQACMNEKCRDPCPGSCGIGARCNVINHTPICTCESGYTGDPFTNC 1495

Query: 400  YPKPPEPIEPVIQEDTCN---CVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRN 456
            YP+PP P EPV ++D CN   C PNA+C +G+C CLP+Y GD Y  CRPECV NSDCPR+
Sbjct: 1496 YPEPPPPREPV-RDDPCNPSPCGPNAQCNNGICTCLPEYQGDPYQGCRPECVLNSDCPRD 1554

Query: 457  KACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQ 516
            KACIR+KC +PC PGTCG+ AIC+V+NH   C+CP G  G+ FVQC+  Q  PV TNPC 
Sbjct: 1555 KACIRSKCIDPC-PGTCGQDAICEVINHIPMCSCPNGMAGNAFVQCRPQQAPPV-TNPCN 1612

Query: 517  PSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGS 576
            PSPCGPNSQCRE+N QAVCSC+P + GSPP CRPEC V+S+CP ++AC NQKC DPCPG+
Sbjct: 1613 PSPCGPNSQCREINGQAVCSCVPGFIGSPPTCRPECVVSSECPQNQACNNQKCRDPCPGT 1672

Query: 577  CGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQ-----------------EDV 619
            CG  A C V+NH+P+CSC   FTG+P +RC  I   P                      V
Sbjct: 1673 CGVGARCSVVNHNPICSCPERFTGDPFVRCQPIIETPVQMTPVNPCQPNPCGPNAECRPV 1732

Query: 620  PEPV--NPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEA--- 674
             EPV  NPC P+PCGP SQCR+I G   CSCLP YIGSPP CRPECV +SECP   A   
Sbjct: 1733 AEPVYKNPCQPNPCGPNSQCREINGQAVCSCLPTYIGSPPGCRPECVTSSECPLDRACVN 1792

Query: 675  ------------------------------------------SRPPPQEDVPEPVNPCYP 692
                                                      + PPPQ+      +PC P
Sbjct: 1793 QKCVDPCPGTCGTNARCNVNNHSPICSCQSGYTGDPFTRCYPNPPPPQDTQVVVRDPCVP 1852

Query: 693  SPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSC 752
            SPCGP SQCR+I G PSCSCL NYIGSPPNCRPEC +N+ECPS++AC+NEKC+DPCPGSC
Sbjct: 1853 SPCGPNSQCRNINGVPSCSCLVNYIGSPPNCRPECTINAECPSNQACMNEKCRDPCPGSC 1912

Query: 753  GYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCNCVPNAECRDGTFL 812
            G  A C VINHTPICTC  G+ GD F+ CYP+PP P +PV ++D CN  P          
Sbjct: 1913 GIGARCNVINHTPICTCESGYTGDPFTNCYPEPPPPREPV-RDDPCNPSP---------- 1961

Query: 813  AEQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVLNNDCPSNKACIRNKCK 872
                        C PNA+C +G+C CLP+Y GD Y  CRPECVLN+DCP +KACIR+KC 
Sbjct: 1962 ------------CGPNAQCNNGICSCLPEYQGDPYQGCRPECVLNSDCPRDKACIRSKCI 2009

Query: 873  NPCVPGTCGQGAVCDVINHAVMCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQ 932
            +PC PGTCGQ A+C+VINH  MC+CP G  G+ FVQC+P                     
Sbjct: 2010 DPC-PGTCGQDAICEVINHIPMCSCPNGMAGNAFVQCRP--------------------- 2047

Query: 933  CREVNKQAPVYTNPCQPSPCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPL 992
                 +QAP  TNPC PSPCGPNSQCRE+N Q+VCSC+P + GSPP CRP C V+S+CP 
Sbjct: 2048 -----QQAPPVTNPCNPSPCGPNSQCREINGQAVCSCVPGFIGSPPTCRPGCVVSSECPQ 2102

Query: 993  DKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGT 1052
            ++AC NQKC DPCPG+CG  A C V+NH+P+CSC   FTG+                   
Sbjct: 2103 NQACNNQKCRDPCPGTCGVGARCSVVNHNPICSCPERFTGD------------------- 2143

Query: 1053 TGSPFVQCKPIQNEPVY---TNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPACRPE 1109
               PFV+C+PI   PV     NPCQP+PCGPN++CR V     C+CL N  GSPP CRPE
Sbjct: 2144 ---PFVRCQPIIETPVQMTPVNPCQPNPCGPNAECRPVGDSPSCTCLDNMIGSPPNCRPE 2200

Query: 1110 CTVNSDCPLNKACQNQKCVDPCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIPP 1169
            C  NS+C  N AC  QKC +PC G CG NA C+V++H+P+C C  G              
Sbjct: 2201 CISNSECASNLACIRQKCQNPCTGACGANAECRVVSHTPMCICSVG-------------- 2246

Query: 1170 PPPPQEPICTCKPGYTGDALSYCNRIPPPPPPQDDVP-EPVNPCYPSPCGLYSECRNVNG 1228
                          YTGD  S C  +      Q DVP EP +PC PSPCG  + CR  NG
Sbjct: 2247 --------------YTGDPFSQCTLV------QQDVPREPSSPCMPSPCGANAICREQNG 2286

Query: 1229 APSCSCLINYIGSP-PNCRPECIQNS---------------------------------- 1253
            A SC+C+ ++IG+P   CRPEC+ NS                                  
Sbjct: 2287 AGSCTCMDDHIGNPYEGCRPECVLNSDCPSDRACIRSKCQDPCPGTCGQNADCQVVNHLP 2346

Query: 1254 -------------LLLGQSLLRTHSAVQPVIQE--DTCN---CVPNAECRD----GVCVC 1291
                                   H  +   IQ+  + C    C PN++CR+     VC C
Sbjct: 2347 SCTCISGYEGDPFRFCNIQQREQHRGIDTSIQQYVNPCQPSPCGPNSQCREINGQAVCSC 2406

Query: 1292 LPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPC-----------VSAVQP------ 1334
            LP Y G     CRPECV +++CP ++AC+  KC +PC           V+   P      
Sbjct: 2407 LPTYIGSP-PGCRPECVTSSECPLDRACVNQKCVDPCPGTCGTNARCNVNNHSPICSCQS 2465

Query: 1335 ---------------------VIQEDTCN---CVPNAECRD--GV--CVCLPEYYGDGYV 1366
                                 V+  D C    C PN++CR+  GV  C CL  Y G    
Sbjct: 2466 GYTGDPFTRCYPNPPPPQDTQVVVRDPCVPSPCGPNSQCRNINGVPSCSCLVNYIGSP-P 2524

Query: 1367 SCRPECVLNNDCPRNKACIKYKCKNPC--------------VHPICSCPQGYIGDGFNGC 1412
            +CRPEC +N +CP N+AC+  KC++PC                PIC+C  GY GD F  C
Sbjct: 2525 NCRPECTINAECPSNQACMNEKCRDPCPGSCGIGARCNVINHTPICTCESGYTGDPFTNC 2584

Query: 1413 Y 1413
            Y
Sbjct: 2585 Y 2585

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi\|270013391\|gb\|EFA09839.1\| hypothetical protein TcasGA2_TC011986 [Tribolium castaneum]	Back alignment and taxonomy information

>gi\|170059512\|ref\|XP_001865395.1\| conserved hypothetical protein [Culex quinquefasciatus] gi\|167878261\|gb\|EDS41644.1\| conserved hypothetical protein [Culex quinquefasciatus]	Back alignment and taxonomy information

>gi\|328714521\|ref\|XP_003245382.1\| PREDICTED: hypothetical protein LOC100166039 [Acyrthosiphon pisum]	Back alignment and taxonomy information

>gi\|442625920\|ref\|NP_001260038.1\| dumpy, isoform W [Drosophila melanogaster] gi\|440213323\|gb\|AGB92574.1\| dumpy, isoform W [Drosophila melanogaster]	Back alignment and taxonomy information

>gi\|442625928\|ref\|NP_001260042.1\| dumpy, isoform AA [Drosophila melanogaster] gi\|440213327\|gb\|AGB92578.1\| dumpy, isoform AA [Drosophila melanogaster]	Back alignment and taxonomy information

>gi\|442625918\|ref\|NP_001260037.1\| dumpy, isoform V [Drosophila melanogaster] gi\|440213322\|gb\|AGB92573.1\| dumpy, isoform V [Drosophila melanogaster]	Back alignment and taxonomy information

>gi\|442625916\|ref\|NP_001260036.1\| dumpy, isoform U [Drosophila melanogaster] gi\|440213321\|gb\|AGB92572.1\| dumpy, isoform U [Drosophila melanogaster]	Back alignment and taxonomy information

>gi\|442625904\|ref\|NP_001260030.1\| dumpy, isoform O [Drosophila melanogaster] gi\|440213315\|gb\|AGB92566.1\| dumpy, isoform O [Drosophila melanogaster]	Back alignment and taxonomy information

>gi\|442625908\|ref\|NP_001260032.1\| dumpy, isoform Q [Drosophila melanogaster] gi\|440213317\|gb\|AGB92568.1\| dumpy, isoform Q [Drosophila melanogaster]	Back alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Alignment graph	Length	Definition	Q cover	H cover	Identity	E-value
Query		1434
FB\|FBgn0053196		22	dp "dumpy" [Drosophila melanog	0.894	58.31	0.413	1.1e-295
MGI\|MGI:97363		2531	Notch1 "notch 1" [Mus musculus	0.827	0.468	0.248	2.9e-54
UNIPROTKB\|P46531		2555	NOTCH1 "Neurogenic locus notch	0.820	0.460	0.250	3.7e-53
UNIPROTKB\|F1MSM3		2534	NOTCH1 "Uncharacterized protei	0.832	0.471	0.246	7.4e-53
RGD\|3188		2471	Notch2 "notch 2" [Rattus norve	0.863	0.501	0.247	1.4e-52
UNIPROTKB\|Q9QW30		2471	Notch2 "Neurogenic locus notch	0.863	0.501	0.247	1.4e-52
ZFIN\|ZDB-GENE-990415-173		2437	notch1a "notch homolog 1a" [Da	0.819	0.482	0.249	1.7e-52
RGD\|3187		2531	Notch1 "notch 1" [Rattus norve	0.828	0.469	0.247	5.3e-52
UNIPROTKB\|Q07008		2531	Notch1 "Neurogenic locus notch	0.828	0.469	0.247	5.3e-52
UNIPROTKB\|P21783		2524	notch1 "Neurogenic locus notch	0.831	0.472	0.239	1.7e-51

FB\|FBgn0053196 dp "dumpy" [Drosophila melanogaster (taxid:7227)]	Back alignment and assigned GO terms

 Score = 2865 (1013.6 bits), Expect = 1.1e-295, P = 1.1e-295
 Identities = 604/1462 (41%), Positives = 772/1462 (52%)

Query:    39 CRVINHTPICTCPQGYVGDAFSGCYPKPPEHPCPGSCGQNANCRVINHSPVCSCKPGFTG 98
             C   NH P C+C + + GD ++ C  K  E              V+   P   C P   G
Sbjct:  9868 CSTQNHQPKCSCIESFEGDPYTAC--KMREI-------------VVLDPPTDPCYPSPCG 9912

Query:    99 EPRIRCNKIPHGVCVCLPDYYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGE 158
                I   +   G C C+ +Y+GD Y++CRPECV NSDCP+N+ACI  KC++PC    CG 
Sbjct:  9913 ANAICRVRNGAGSCSCIQNYFGDPYINCRPECVQNSDCPNNRACINMKCRDPCA-NACGF 9971

Query:   159 GAICNVENHAVMCTCPPGTTGSPFIQC--KPVQNE-PVYTNPCQPSPCGPNSQCREINSQ 215
              AIC V +H  +C+C P  TG+P   C  +P     P+  +PC+PSPCG  S C  +  +
Sbjct:  9972 NAICRVAHHQPVCSCEPHLTGNPLRACVERPSNMYLPLPKDPCRPSPCGLFSTCHVVGER 10031

Query:   216 AVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQKCVDPCPGTCGQNANCRVINHSPIC 275
              VC+CLP+Y G+PP C+PEC  +++C   +AC NQ+C DPCPGTCG NA CR  NHSPIC
Sbjct: 10032 PVCACLPDYMGAPPNCKPECMTSAECPSDRACINQRCKDPCPGTCGYNARCRCTNHSPIC 10091

Query:   276 TCKPGFTGDALVYC--NRIPPSRPLESPPEYVNPCVPSPCGPYAQCRDINGSPSCSCLPN 333
             +C  G+TGD    C   R PP  P+  P    NPCVPSPCGP +QC+  +    CSC+ N
Sbjct: 10092 SCYDGYTGDPFHQCVPERKPP--PIADPIVPPNPCVPSPCGPNSQCQVSSSGAVCSCVTN 10149

Query:   334 YIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIG 393
             YIG PP CRPEC  NSECP   ACIN +CADPC+GSCG  A+C V  H+P+C C  G+ G
Sbjct: 10150 YIGRPPGCRPECSINSECPARMACINARCADPCIGSCGNNALCHVSLHAPVCMCEPGYSG 10209

Query:   394 DAFSSCYPKPPEPIEPVIQEDTCN-CVPNAECRD----GVCLCLPDYYGDGYVSCRPECV 448
             D FS CY     PIE VIQ    + C  NA C +      C CLP+Y+GD YV CRPECV
Sbjct: 10210 DPFSGCYKIIETPIE-VIQPCRPSPCGLNALCEERNQAAACKCLPEYFGDPYVECRPECV 10268

Query:   449 QNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYE 508
              NSDCPR++AC+  KC +PC PG CG  A+C V NHA +C C PG TG+P V C  +   
Sbjct: 10269 INSDCPRSRACVNQKCVDPC-PGMCGHNALCAVFNHAPNCECLPGYTGNPIVGCHIVPES 10327

Query:   509 PVYT------NPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDK 562
             P Y       NPCQPSPCG  S CR VN  AVCSC+P+Y GSPP CRPEC  +S+C  DK
Sbjct: 10328 PRYPDPIVPENPCQPSPCGLYSNCRPVNGHAVCSCVPSYIGSPPNCRPECMSSSECAQDK 10387

Query:   563 ACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIXXXXXXXXXXXXX 622
             +C+N++C DPCPG+CG NA CRV+NH+P+CSC PGF+G+P +RC                
Sbjct: 10388 SCLNERCKDPCPGTCGNNALCRVVNHNPICSCSPGFSGDPFVRC---FPQEKRPPITHDR 10444

Query:   623 XXXCYPSPCGPYSQCRDIGGSPS--CSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQ 680
                C PSPCGP S+CR    +    CSCL +Y+G  PNCRPEC  +SECP + A      
Sbjct: 10445 IDPCVPSPCGPNSECRVSAANEQAVCSCLQHYVGRAPNCRPECTSDSECPGNLACINLRC 10504

Query:   681 EDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEACI 740
              D      PC  + CG  + C      P C C+  Y G P          SEC S +  +
Sbjct: 10505 RD------PCVGT-CGIQTTCLVNNHRPICRCIDGYAGDP---------FSEC-SPKINV 10547

Query:   741 NEKCQDPC-PGSCGYNAECKVINHTPICTCPQGFIGDAFSGCYPKPPEPEQPVIQEDTCN 799
               +   PC P  CG NA CK  N    C+C   + GD ++ C P      + V+  D C+
Sbjct: 10548 PVQVAQPCNPSPCGANAVCKERNGVGSCSCLPEYNGDPYTECRP------ECVLNSD-CS 10600

Query:   800 ----CVPNAECRD---GT--FLAEQPVIQE-DTCNCV------PNAECRD------GVCV 837
                 C+ N +CRD   G     AE  VI    +C+C       P+  CR+       V  
Sbjct: 10601 KNRACLNN-KCRDPCPGVCGVSAECHVINHAPSCSCPSGFTGNPSQFCREIPRLPAPVEP 10659

Query:   838 CLPDYYGDGYVSCRP---ECVLNNDCPSNKACIRNKCKNPC-VPGTCGQGAVCDVINHAV 893
             C P   G  Y  CR      V +  C +N       C+  C V   C Q   C  +N   
Sbjct: 10660 CRPSPCGP-YSQCREVNGHAVCS--CVTNYIGTPPACRPECSVSSECAQDRAC--VNQRC 10714

Query:   894 MCTCPPGTTGSPFVQCKPIQNEPVYTNPCQPSPCGPNSQC---REVNKQAPVYTNPCQPS 950
                CP GT G+  + CK   + P+ + P   S   P  +C   +E  +Q     NPC PS
Sbjct: 10715 ADPCP-GTCGNEAI-CKVTNHNPICSCPAGYSG-DPFVRCAPWQEEPEQPKSNENPCVPS 10771

Query:   951 PCGPNSQCREVNKQSVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPCPGSCG 1010
             PCG NSQCR V +  VCSCLPN+ G  P CRPECT+N++CP + AC+N++C DPCPGSCG
Sbjct: 10772 PCGRNSQCRVVGETGVCSCLPNFVGRAPNCRPECTINTECPANLACINERCQDPCPGSCG 10831

Query:  1011 QNANCRVINHSPVCSCKPGFTGEPRIRCNRIHAVMCTCPPGTTGSPFVQCKPIQNEPVYT 1070
              NA C V+NHSP+C+C  G+TG+P   CN         PP            I +E +  
Sbjct: 10832 FNAFCSVVNHSPICTCDSGYTGDPFAGCN-------PQPPA-----------IPDERL-- 10871

Query:  1071 NPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSP-PACRPECTVNSDCPLNKACQNQKCVD 1129
              PCQPSPCGPN++CRE N    C+CLP YFG P   CRPEC VNSDC  +K+C NQKCVD
Sbjct: 10872 TPCQPSPCGPNAECRERNGAGSCTCLPEYFGDPYSGCRPECVVNSDCSRDKSCVNQKCVD 10931

Query:  1130 PCPGTCGQNANCKVINHSPICTCKPGYTGDALSYCNRIXXX----XXXQEP--------- 1176
             PCPG CG NA C+V NH P C+C  GYTG+  S C  I          + P         
Sbjct: 10932 PCPGVCGLNAQCRVSNHLPSCSCLAGYTGNPSSACREIPQLPPPPERDENPCRPSPCGPY 10991

Query:  1177 ----------ICTCKPGYTGDALSYCNRIXXXXXXXXXXXXXXXXCY-PSP--CGLYSEC 1223
                       +C+C  G+ G A +                     C  P P  CG+ + C
Sbjct: 10992 SQCREVDGHAVCSCLQGFIGSAPNCRPECIISSDCAQNLNCQNQKCVDPCPGTCGIEARC 11051

Query:  1224 RNVNGAPSCSCLINYIGSPPNCRPECIQNSLLLGQSLLRTHSAVQPVIQEDTCNCVPNAE 1283
             + +N  P+CSC   + G P N    C +  +LL      T  +  P I      C PN++
Sbjct: 11052 QVINHYPACSCAPGFTGDPFN---RCTK--ILLEPP--PTEKSGNPCIPSP---CGPNSK 11101

Query:  1284 CRD--G--VCVCLPDYYGDGYVSCRPECVLNNDCPRNKACIKYKCKNPCVSAVQPVIQED 1339
             C D  G   C CLPDY G    +CRPEC+ + DCP N AC+  +C NPC+ A        
Sbjct: 11102 CLDVRGSPACSCLPDYLGRP-PNCRPECLSSADCPANLACVNQRCSNPCIGACG---LHS 11157

Query:  1340 TCNCVPNAECRDGVCVCLPEYYGDGYVSCR------PECVLNNDCPRNKACIKYKCKNPC 1393
              C  + +       C C+P Y GD +  C       P     N C  +       C+   
Sbjct: 11158 VCTVIKHRPA----CECVPGYTGDPFSGCAIVQQIAPPDETRNPCNPSPCGANAICRERN 11213

Query:  1394 VHPICSCPQGYIGDGFNGCYPK 1415
                 C+C   Y GD ++GC P+
Sbjct: 11214 GAGSCACLPEYFGDPYSGCRPE 11235

GO:0007475 "apposition of dorsal and ventral imaginal disc-derived wing surfaces" evidence=IMP

GO:0005578 "proteinaceous extracellular matrix" evidence=NAS

GO:0007424 "open tracheal system development" evidence=IMP

GO:0051539 "4 iron, 4 sulfur cluster binding" evidence=IEA

GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA

GO:0004519 "endonuclease activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0008362 "chitin-based embryonic cuticle biosynthetic process" evidence=IMP

GO:0040005 "chitin-based cuticle attachment to epithelium" evidence=IMP

GO:0031012 "extracellular matrix" evidence=ISM

GO:0005201 "extracellular matrix structural constituent" evidence=ISM

GO:0046331 "lateral inhibition" evidence=IMP

MGI\|MGI:97363 Notch1 "notch 1" [Mus musculus (taxid:10090)]	Back alignment and assigned GO terms

UNIPROTKB\|P46531 NOTCH1 "Neurogenic locus notch homolog protein 1" [Homo sapiens (taxid:9606)]	Back alignment and assigned GO terms

UNIPROTKB\|F1MSM3 NOTCH1 "Uncharacterized protein" [Bos taurus (taxid:9913)]	Back alignment and assigned GO terms

RGD\|3188 Notch2 "notch 2" [Rattus norvegicus (taxid:10116)]	Back alignment and assigned GO terms

UNIPROTKB\|Q9QW30 Notch2 "Neurogenic locus notch homolog protein 2" [Rattus norvegicus (taxid:10116)]	Back alignment and assigned GO terms

ZFIN\|ZDB-GENE-990415-173 notch1a "notch homolog 1a" [Danio rerio (taxid:7955)]	Back alignment and assigned GO terms

RGD\|3187 Notch1 "notch 1" [Rattus norvegicus (taxid:10116)]	Back alignment and assigned GO terms

UNIPROTKB\|Q07008 Notch1 "Neurogenic locus notch homolog protein 1" [Rattus norvegicus (taxid:10116)]	Back alignment and assigned GO terms

UNIPROTKB\|P21783 notch1 "Neurogenic locus notch protein homolog" [Xenopus laevis (taxid:8355)]	Back alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

No hit with e-value below 0.005

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Alignment Graph	Length	Definition	Probability
Query		1434
KOG1217\|consensus		487		99.64
KOG1214\|consensus		1289		99.63
KOG4289\|consensus		2531		99.62
KOG1217\|consensus		487		99.61
KOG4289\|consensus		2531		99.59
KOG1214\|consensus		1289		99.45
KOG0994\|consensus		1758		99.28
KOG1219\|consensus		4289		99.17
KOG1219\|consensus		4289		99.15
KOG0994\|consensus		1758		99.03
KOG1225\|consensus		525		99.01
KOG1225\|consensus		525		98.84
KOG4260\|consensus		350		98.48
KOG4260\|consensus		350		98.47
PF07645		42	EGF_CA: Calcium-binding EGF domain; InterPro: IPR0	97.8
KOG1836\|consensus		1705		97.77
KOG1836\|consensus		1705		97.65
KOG1226\|consensus		783		97.57
PF12947		36	EGF_3: EGF domain; InterPro: IPR024731 This entry	97.56
PF07645		42	EGF_CA: Calcium-binding EGF domain; InterPro: IPR0	97.5
PF06247		197	Plasmod_Pvs28: Plasmodium ookinete surface protein	97.43
PF00008		32	EGF: EGF-like domain This is a sub-family of the P	97.42
smart00179		39	EGF_CA Calcium-binding EGF-like domain.	97.41
PF00008		32	EGF: EGF-like domain This is a sub-family of the P	97.41
PF06247		197	Plasmod_Pvs28: Plasmodium ookinete surface protein	97.29
smart00179		39	EGF_CA Calcium-binding EGF-like domain.	97.13
cd00054		38	EGF_CA Calcium-binding EGF-like domain, present in	96.91
PF12947		36	EGF_3: EGF domain; InterPro: IPR024731 This entry	96.76
KOG1226\|consensus		783		96.68
cd00054		38	EGF_CA Calcium-binding EGF-like domain, present in	96.47
cd00053		36	EGF Epidermal growth factor domain, found in epide	95.92
smart00181		35	EGF Epidermal growth factor-like domain.	95.62
cd00053		36	EGF Epidermal growth factor domain, found in epide	95.54
smart00181		35	EGF Epidermal growth factor-like domain.	95.2
PF12662		24	cEGF: Complement Clr-like EGF-like	95.08
PF12662		24	cEGF: Complement Clr-like EGF-like	94.74
KOG1218\|consensus		316		94.09
PF07974		32	EGF_2: EGF-like domain; InterPro: IPR013111 A sequ	92.79
KOG1218\|consensus		316		92.13
PF12661		13	hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E	91.69
PF07974		32	EGF_2: EGF-like domain; InterPro: IPR013111 A sequ	91.11
PF12946		37	EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730	90.28
PF14670		36	FXa_inhibition: Coagulation Factor Xa inhibitory s	90.2
smart00051		63	DSL delta serrate ligand.	88.89
PF14670		36	FXa_inhibition: Coagulation Factor Xa inhibitory s	88.14
smart00051		63	DSL delta serrate ligand.	86.59
PF12946		37	EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730	81.82

>KOG1217\|consensus	Back alignment and domain information

Probab=99.64  E-value=4.6e-14  Score=176.72  Aligned_cols=326  Identities=28%  Similarity=0.620  Sum_probs=229.0

Q ss_pred             CCCCceeecCCCceeeCCCCcccCCccccccCCCCCCCCCCCCcCCCCCCCC--CCCCCccccC---CCCCcccCCCCcc
Q psy13157        261 GQNANCRVINHSPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVNPCVPSP--CGPYAQCRDI---NGSPSCSCLPNYI  335 (1434)
Q Consensus       261 ~~~~~C~~~~g~y~C~C~~Gf~G~~c~~C~~~~~~~~~~~~~~dideC~~~~--C~~~g~C~n~---~gsy~C~C~~Gy~  335 (1434)
                      ...+.+.....+|.|.|++||.|..+..                ..+|...+  +...+.|.+.   ...|.|.|..||.
T Consensus        98 ~~~~~~~~~~~~~~c~c~~g~~~~~~~~----------------~~~C~~~~~~~~~~~~c~~~~~~~~~~~c~C~~g~~  161 (487)
T KOG1217|consen   98 LLCGECVDCVGSYECTCPPGYQGTPCEG----------------ECECVTGPGVCCIDGSCSNGPGSVGPFRCSCTEGYE  161 (487)
T ss_pred             cCCccccCCCCCceeeCCCccccCcCCc----------------ceeecCCCCCeeCchhhcCCCCCCCceeeeeCCCcc
Confidence            3445666678899999999999987531                11465544  3456777764   4589999999999


Q ss_pred             CCCCCCCCCCccCCCCCCCCcccCCCCCCCCCCCCCCCCeeeecCCCccccCCCCCccCCCcccCCCCCCCCCCCCCCCC
Q psy13157        336 GAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDT  415 (1434)
Q Consensus       336 g~~~~C~~~C~~~~eC~~~~~C~~~~C~~~C~~~C~~~~~C~~~~gsy~C~C~~G~~G~~c~~C~~~~~~~~~~c~~~~~  415 (1434)
                      +.  .++.   ..++|....            +.|.+++.|.+..++|.|.|++||++..++.-                
T Consensus       162 ~~--~~~~---~~~~C~~~~------------~~c~~~~~C~~~~~~~~C~c~~~~~~~~~~~~----------------  208 (487)
T KOG1217|consen  162 GE--PCET---DLDECIQYS------------SPCQNGGTCVNTGGSYLCSCPPGYTGSTCETT----------------  208 (487)
T ss_pred             cc--cccc---cccccccCC------------CCcCCCcccccCCCCeeEeCCCCccCCcCcCC----------------
Confidence            98  5542   224555331            35778899999999999999999999987620                


Q ss_pred             CCCCCCCeeec-ceeccCCCcccCCCccCCCccccCCCCCCCcccccCCCCCCCCCCCCCCCCEEeccCCceEeeCCCCC
Q psy13157        416 CNCVPNAECRD-GVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCGEGAICDVVNHAVSCTCPPGT  494 (1434)
Q Consensus       416 c~C~~~~~C~~-~~C~C~~Gy~G~~~~~c~~~C~~~~~C~~~~~C~~~~C~~~C~~~~C~~~~~C~~~~g~y~C~C~~G~  494 (1434)
                         .+.+.|++ ..|.+.+||.+..+...                     +.+|...   + ++|.+..++|+|.|++||
T Consensus       209 ---~~~~~c~~~~~~~~~~g~~~~~c~~~---------------------~~~~~~~---~-~~c~~~~~~~~C~~~~g~  260 (487)
T KOG1217|consen  209 ---GNGGTCVDSVACSCPPGARGPECEVS---------------------IVECASG---D-GTCVNTVGSYTCRCPEGY  260 (487)
T ss_pred             ---CCCceEecceeccCCCCCCCCCcccc---------------------cccccCC---C-CcccccCCceeeeCCCCc
Confidence               23455654 36889999987763321                     1222222   3 789999999999999999


Q ss_pred             cCCCCccccccccCCCCCCCCCCC-CCCCCceeeccCCCeeeeCCCCCcCCCCCCcCCCccCCCCCCCCcccCCcccCCC
Q psy13157        495 TGSPFVQCKTIQYEPVYTNPCQPS-PCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTVNSDCPLDKACVNQKCVDPC  573 (1434)
Q Consensus       495 ~G~~~~~C~~~~~~~~~~d~C~~~-~C~~~g~C~~~~g~y~C~C~~Gy~G~~~~c~~~C~~~~~C~~~~~C~~~~C~~~C  573 (1434)
                      ++.....+.       ++++|+.. +|.++++|+++.+.|.|.|++||+|.      .|   ..+.....|...    .-
T Consensus       261 ~~~~~~~~~-------~~~~C~~~~~c~~~~~C~~~~~~~~C~C~~g~~g~------~~---~~~~~~~~C~~~----~~  320 (487)
T KOG1217|consen  261 TGDACVTCV-------DVDSCALIASCPNGGTCVNVPGSYRCTCPPGFTGR------LC---TECVDVDECSPR----NA  320 (487)
T ss_pred             cccccceee-------eccccCCCCccCCCCeeecCCCcceeeCCCCCCCC------CC---cccccccccccc----cc
Confidence            998611233       47899865 39999999999999999999999999      33   112222344211    00


Q ss_pred             CCCCCCCcee--eecCCCceeeCCCCCccCCCCcccCCCCCCCCCCCCCCCC-CCCCCCCCCCCCeeEe-cCCCceeeCC
Q psy13157        574 PGSCGQNANC--RVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPV-NPCYPSPCGPYSQCRD-IGGSPSCSCL  649 (1434)
Q Consensus       574 ~~~C~~~~~C--~~~~g~~~C~C~~Gy~G~~~~~C~~~~~~~~~~~~c~~di-deC~~~~C~~~~~C~n-~~gsy~C~C~  649 (1434)
                      ...|.++++|  ....+.+.|.|..||.|..   |+              .+ ++|...++.+++.|++ ..++|.|.++
T Consensus       321 ~~~c~~g~~C~~~~~~~~~~C~c~~~~~g~~---C~--------------~~~~~C~~~~~~~~~~c~~~~~~~~~c~~~  383 (487)
T KOG1217|consen  321 GGPCANGGTCNTLGSFGGFRCACGPGFTGRR---CE--------------DSNDECASSPCCPGGTCVNETPGSYRCACP  383 (487)
T ss_pred             CCcCCCCcccccCCCCCCCCcCCCCCCCCCc---cc--------------cCCccccCCccccCCEeccCCCCCeEecCC
Confidence            3457777788  3344678899999998887   85              34 5898888999999999 7899999999


Q ss_pred             CCCcCC-CCCCccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeeeccCCCceeeCCCCcccCCCCCccCCc
Q psy13157        650 PNYIGS-PPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLPNYIGSPPNCRPECV  728 (1434)
Q Consensus       650 ~Gy~g~-~~~C~~~C~~~~~C~~~~~~~~~~~~~~~~~ideC~~~~C~~~~~C~n~~gsy~C~C~~Gy~G~~~~C~~~C~  728 (1434)
                      .+|.+. ....                      ..+.++++|..     .+.|++..++|.|. ++ + ... ..  .|.
T Consensus       384 ~~~~~~~~~~~----------------------~~~~~~~~c~~-----~~~c~~~~~~~~c~-~~-~-~~~-~~--~~~  430 (487)
T KOG1217|consen  384 AGFAGKANGDG----------------------VGCEDIDECSG-----CGDCVNGPGGGACT-PP-G-LVS-PG--TCD  430 (487)
T ss_pred             CccccCCcccc----------------------ccccccccccC-----CcceeccCCCCccc-cC-c-ccC-Cc--cee
Confidence            999984 1111                      12256677755     56788889999999 88 5 332 22  455


Q ss_pred             cCCCC
Q psy13157        729 MNSEC  733 (1434)
Q Consensus       729 ~~~eC  733 (1434)
                      +++++
T Consensus       431 ~~~~~  435 (487)
T KOG1217|consen  431 DIDEC  435 (487)
T ss_pred             ccccc
Confidence            55544

>KOG1214\|consensus	Back alignment and domain information

>KOG4289\|consensus	Back alignment and domain information

>KOG1217\|consensus	Back alignment and domain information

>KOG4289\|consensus	Back alignment and domain information

>KOG1214\|consensus	Back alignment and domain information

>KOG0994\|consensus	Back alignment and domain information

>KOG1219\|consensus	Back alignment and domain information

>KOG1219\|consensus	Back alignment and domain information

>KOG0994\|consensus	Back alignment and domain information

>KOG1225\|consensus	Back alignment and domain information

>KOG1225\|consensus	Back alignment and domain information

>KOG4260\|consensus	Back alignment and domain information

>KOG4260\|consensus	Back alignment and domain information

>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins	Back alignment and domain information

>KOG1836\|consensus	Back alignment and domain information

>KOG1836\|consensus	Back alignment and domain information

>KOG1226\|consensus	Back alignment and domain information

>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins	Back alignment and domain information

>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins	Back alignment and domain information

>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium	Back alignment and domain information

>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins	Back alignment and domain information

>smart00179 EGF_CA Calcium-binding EGF-like domain	Back alignment and domain information

>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins	Back alignment and domain information

>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium	Back alignment and domain information

>smart00179 EGF_CA Calcium-binding EGF-like domain	Back alignment and domain information

>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins	Back alignment and domain information

>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins	Back alignment and domain information

>KOG1226\|consensus	Back alignment and domain information

>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins	Back alignment and domain information

>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium

Back alignment and domain information

>smart00181 EGF Epidermal growth factor-like domain	Back alignment and domain information

Back alignment and domain information

>smart00181 EGF Epidermal growth factor-like domain	Back alignment and domain information

>PF12662 cEGF: Complement Clr-like EGF-like	Back alignment and domain information

>PF12662 cEGF: Complement Clr-like EGF-like	Back alignment and domain information

>KOG1218\|consensus	Back alignment and domain information

>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins	Back alignment and domain information

>KOG1218\|consensus	Back alignment and domain information

>PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A	Back alignment and domain information

>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins	Back alignment and domain information

>PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein	Back alignment and domain information

>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A	Back alignment and domain information

>smart00051 DSL delta serrate ligand	Back alignment and domain information

>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A	Back alignment and domain information

>smart00051 DSL delta serrate ligand	Back alignment and domain information

>PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein	Back alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Alignment Graph	Length	Definition	E-value
Query		1434
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	1e-06
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	4e-05
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	3e-04
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	4e-04
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	8e-04
1yo8_A		634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	5e-05
1yo8_A		634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	5e-04
1yo8_A		634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	5e-04
1nfu_B		195	Coagulation factor XA, light chain; hydrolase; HET	1e-04
2bou_A		143	EGF-like module containing mucin-like hormone rece	3e-04
1uzk_A		162	Fibrillin-1; glycoprotein, extra-cellular matrix,	4e-04
2dtg_E		897	Insulin receptor; IR ectodomain, X-RAY crystallogr	9e-04

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687	Back alignment and structure

 Score = 52.4 bits (125), Expect = 1e-06
 Identities = 46/342 (13%), Positives = 65/342 (19%), Gaps = 38/342 (11%)

Query: 194 YTNPCQPSPCGPNSQ---CREINSQAVCSCLPNYFGSPPACRPECTVNSDCLQSKACFNQ 250
           Y + C       N     C  +      +       +         + +           
Sbjct: 360 YDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQV 419

Query: 251 KCVDPCPGTCGQNANCRVINH----SPICTCKPGFTGDALVYCNRIPPSRPLESPPEYVN 306
                C                     IC C  G+ G     C                 
Sbjct: 420 LPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGK---NCE--------------CQ 462

Query: 307 PCVPSPCGPYAQCRDINGSPSCSCLPNYIGAPPNCRPECVQNSECPHDKACINEKCADPC 366
               S       CR  N S  CS L + +     C        +  + + C  +      
Sbjct: 463 TQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSD-VPGKLIYGQYCECDTINCER 521

Query: 367 LGSCGYGAVCTVINHSPICTCPEGFIGDAFSSCYPKPPEPIEPVIQEDTCNCVPNAECRD 426
                 G     +     C C  GF G A            E  +      C     CR 
Sbjct: 522 YNGQVCGGPGRGLCFCGKCRCHPGFEGSACQC-----ERTTEGCLNPRRVECSGRGRCRC 576

Query: 427 GVCLCLPDYYGDG---YVSCRPECVQNSDCPRNKACIR----NKCKNPCTPGTCGEGAIC 479
            VC C   Y          C   C +   C       +      C   C         + 
Sbjct: 577 NVCECHSGYQLPLCQECPGCPSPCGKYISCAECLKFEKGPFGKNCSAACPGLQLSNNPVK 636

Query: 480 DVV-NHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPC 520
                   S  C    T                +  C   P 
Sbjct: 637 GRTCKERDSEGCWVAYTLEQQDGMDRYLIYVDESRECVAGPD 678

PyMOL of 3k6s

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687	Back alignment and structure

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687	Back alignment and structure

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687	Back alignment and structure

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687	Back alignment and structure

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634	Back alignment and structure

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634	Back alignment and structure

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634	Back alignment and structure

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195	Back alignment and structure

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143	Back alignment and structure

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162	Back alignment and structure

>2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E Length = 897	Back alignment and structure

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Alignment Graph	Length	Definition	Probability
Query		1434
4fbr_A		267	Lectin, myxobacterial hemagglutinin; beta-barrel,	99.82
4fbr_A		267	Lectin, myxobacterial hemagglutinin; beta-barrel,	99.81
1z1y_A		186	Ookinete surface protein PVS25; four EGF-like doma	99.76
2vj3_A		135	Neurogenic locus notch homolog protein 1; transcri	99.73
1z1y_A		186	Ookinete surface protein PVS25; four EGF-like doma	99.73
2vj3_A		135	Neurogenic locus notch homolog protein 1; transcri	99.72
2ygq_A		324	WIF-1, WNT inhibitory factor 1; signaling protein,	99.65
1uzk_A		162	Fibrillin-1; glycoprotein, extra-cellular matrix,	99.63
4d90_A		143	EGF-like repeat and discoidin I-like domain-conta	99.61
2ygq_A		324	WIF-1, WNT inhibitory factor 1; signaling protein,	99.6
4d90_A		143	EGF-like repeat and discoidin I-like domain-conta	99.6
2vj2_A		169	Jagged-1; signalling, polymorphism, glycoprotein,	99.6
1uzk_A		162	Fibrillin-1; glycoprotein, extra-cellular matrix,	99.59
2vj2_A		169	Jagged-1; signalling, polymorphism, glycoprotein,	99.58
2bou_A		143	EGF-like module containing mucin-like hormone rece	99.56
1yo8_A		634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	99.54
1yo8_A		634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	99.53
2bou_A		143	EGF-like module containing mucin-like hormone rece	99.5
3fcs_B		690	Integrin beta-3; beta propeller, rossmann fold, EG	99.48
3fcs_B		690	Integrin beta-3; beta propeller, rossmann fold, EG	99.41
1dx5_I		118	Thrombomodulin; serine proteinase, EGF-like domain	99.37
2gy5_A		423	Angiopoietin-1 receptor; ligand-binding domain, tr	99.35
2w86_A		147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	99.34
2gy5_A		423	Angiopoietin-1 receptor; ligand-binding domain, tr	99.34
2w86_A		147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	99.33
1dx5_I		118	Thrombomodulin; serine proteinase, EGF-like domain	99.29
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	99.25
1tpg_A		91	T-plasminogen activator F1-G; plasminogen activati	99.12
1tpg_A		91	T-plasminogen activator F1-G; plasminogen activati	99.1
4aqs_A		525	Laminin subunit beta-1; cell adhesion; HET: NAG BM	99.1
1emn_A		82	Fibrillin; extracellular matrix, calcium-binding,	99.09
3k6s_B		687	Integrin beta-2; cell receptor, adhesion molecule,	99.08
1lmj_A		86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	99.04
1emn_A		82	Fibrillin; extracellular matrix, calcium-binding,	98.99
1lmj_A		86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	98.97
1aut_L		114	Activated protein C; serine proteinase, plasma cal	98.95
4aqs_A		525	Laminin subunit beta-1; cell adhesion; HET: NAG BM	98.95
1z6c_A		87	Vitamin K-dependent protein S; EGF module, blood c	98.9
1z6c_A		87	Vitamin K-dependent protein S; EGF module, blood c	98.88
1x7a_L		146	Coagulation factor IX, light chain; inhibition, bl	98.88
1aut_L		114	Activated protein C; serine proteinase, plasma cal	98.86
2c4f_L		142	Coagulation factor VII precursor; blood coagulatio	98.79
1x7a_L		146	Coagulation factor IX, light chain; inhibition, bl	98.77
2c4f_L		142	Coagulation factor VII precursor; blood coagulatio	98.73
3h5c_B		317	Vitamin K-dependent protein Z; protein Z-protein Z	98.67
1nfu_B		195	Coagulation factor XA, light chain; hydrolase; HET	98.65
2vh0_B		134	Activated factor XA light chain; serine protease,	98.65
1nfu_B		195	Coagulation factor XA, light chain; hydrolase; HET	98.64
2w2n_E		107	LDL receptor, low-density lipoprotein receptor; hy	98.62
2vh0_B		134	Activated factor XA light chain; serine protease,	98.61
2w2n_E		107	LDL receptor, low-density lipoprotein receptor; hy	98.61
1n7d_A		699	LDL receptor, low-density lipoprotein receptor; fa	98.53
1klo_A		162	Laminin; glycoprotein; 2.10A {Mus musculus} SCOP:	98.47
3h5c_B		317	Vitamin K-dependent protein Z; protein Z-protein Z	98.46
2p28_B		217	Integrin beta-2; hybrid domain, PSI domain, I-EGF	98.44
1n7d_A		699	LDL receptor, low-density lipoprotein receptor; fa	98.43
3m0c_C		791	LDL receptor, low-density lipoprotein receptor; pr	98.39
1klo_A		162	Laminin; glycoprotein; 2.10A {Mus musculus} SCOP:	98.29
3m0c_C		791	LDL receptor, low-density lipoprotein receptor; pr	98.25
1edm_B		39	Factor IX; epidermal growth factor, EGF, calcium-	98.21
3u7u_G		55	Neuregulin 1; signaling protein, transferase-trans	98.11
1edm_B		39	Factor IX; epidermal growth factor, EGF, calcium-	98.11
2p28_B		217	Integrin beta-2; hybrid domain, PSI domain, I-EGF	98.08
3p5b_L		400	Low density lipoprotein receptor variant; B-propel	98.01
3p5b_L		400	Low density lipoprotein receptor variant; B-propel	97.99
3u7u_G		55	Neuregulin 1; signaling protein, transferase-trans	97.98
3v65_B		386	Low-density lipoprotein receptor-related protein;	97.86
3v65_B		386	Low-density lipoprotein receptor-related protein;	97.85
2k2s_B		61	Micronemal protein 6; microneme protein complex, c	97.77
1egf_A		53	Epidermal growth factor; NMR {Mus musculus} SCOP:	97.64
1egf_A		53	Epidermal growth factor; NMR {Mus musculus} SCOP:	97.61
2k2s_B		61	Micronemal protein 6; microneme protein complex, c	97.6
1a3p_A		45	Epidermal growth factor; disulfide connectivities,	97.51
1a3p_A		45	Epidermal growth factor; disulfide connectivities,	97.37
1k36_A		46	Epiregulin; EGF-like fold, hormone/growth factor c	97.33
2wg3_C		463	Hedgehog-interacting protein; lipoprotein, develop	97.32
1hae_A		63	Heregulin-alpha; growth factor; NMR {Homo sapiens}	97.3
2kl7_A		71	Fibulin-4; secreted, calcium, disease mutation, di	97.26
1k36_A		46	Epiregulin; EGF-like fold, hormone/growth factor c	97.24
2wg3_C		463	Hedgehog-interacting protein; lipoprotein, develop	97.21
1apq_A		53	Complement protease C1R; EGF, calcium binding, ser	97.21
3zyj_B		426	Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA	97.07
3ca7_A		52	Protein spitz; argos, EGF, developmental protein,	97.02
1hae_A		63	Heregulin-alpha; growth factor; NMR {Homo sapiens}	96.93
1gl4_A		285	Nidogen-1, entactin; immunoglobulin-like domain, e	96.92
3ca7_A		52	Protein spitz; argos, EGF, developmental protein,	96.91
3zyj_B		426	Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA	96.84
1apq_A		53	Complement protease C1R; EGF, calcium binding, ser	96.57
2kl7_A		71	Fibulin-4; secreted, calcium, disease mutation, di	96.5
2jkh_L		55	Factor X light chain; plasma, calcium, zymogen, se	96.23
1ob1_C		99	Major merozoite surface protein; immune system, im	96.21
1ob1_C		99	Major merozoite surface protein; immune system, im	96.2
1nql_B		53	Epidermal growth factor; cell surface receptor, ty	96.16
1nql_B		53	Epidermal growth factor; cell surface receptor, ty	96.13
1kli_L		69	Factor VIIA; extrinsic coagulation pathway, serine	96.09
2jkh_L		55	Factor X light chain; plasma, calcium, zymogen, se	95.86
1gl4_A		285	Nidogen-1, entactin; immunoglobulin-like domain, e	95.64
1g1s_A		162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	95.52
1kli_L		69	Factor VIIA; extrinsic coagulation pathway, serine	95.51
1n1i_A		105	Merozoite surface protein-1; MSP1, malaria, surfac	95.3
1g1s_A		162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	95.28
1n1i_A		105	Merozoite surface protein-1; MSP1, malaria, surfac	95.02
2fd6_A		122	Urokinase-type plasminogen activator; UPAR, ATF, A	94.89
2fd6_A		122	Urokinase-type plasminogen activator; UPAR, ATF, A	94.38
3ltf_D		58	Protein spitz; receptor-ligand complex ectodomain	94.26
1kig_L		51	Factor XA; glycoprotein, serine protease, plasma,	94.19
1kig_L		51	Factor XA; glycoprotein, serine protease, plasma,	94.03
1szb_A		170	Mannose binding lectin-associated serine protease-	93.77
3ltf_D		58	Protein spitz; receptor-ligand complex ectodomain	93.74
1q4g_A		553	Prostaglandin G/H synthase 1; cyclooxygenase, non-	92.89
2bz6_L		53	Blood coagulation factor VIIA; serine protease, en	92.88
1oig_A		26	Dumpy, CG33196-PB; structural protein; NMR {Drosop	92.53
3nt1_A		587	Prostaglandin-endoperoxide synthase 2; prostagland	92.43
1q4g_A		553	Prostaglandin G/H synthase 1; cyclooxygenase, non-	92.26
3nt1_A		587	Prostaglandin-endoperoxide synthase 2; prostagland	92.17
1oig_A		26	Dumpy, CG33196-PB; structural protein; NMR {Drosop	92.15
2bz6_L		53	Blood coagulation factor VIIA; serine protease, en	91.44
3cfw_A		164	L-selectin; EGF, cell adhesion, EGF-like domain, g	90.68
3cfw_A		164	L-selectin; EGF, cell adhesion, EGF-like domain, g	90.66
4aqt_A		375	Laminin subunit gamma-1; cell adhesion; HET: NAG B	89.09
1szb_A		170	Mannose binding lectin-associated serine protease-	88.43
4aqt_A		375	Laminin subunit gamma-1; cell adhesion; HET: NAG B	87.14
2i9a_A		145	Urokinase-type plasminogen activator; growth facto	86.98
2y38_A		403	Laminin subunit alpha-5; structural protein, cell	86.94
2y38_A		403	Laminin subunit alpha-5; structural protein, cell	86.89
1xdt_R		79	Hbegf, heparin-binding epidermal growth factor; co	85.58
1g1t_A		157	E-selectin; EGF, adhesion molecule, SLEX, immune s	85.47
1g1t_A		157	E-selectin; EGF, adhesion molecule, SLEX, immune s	85.12
2wph_E		59	Coagulation factor IXA light chain; serine proteas	84.63
2rnl_A		50	Amphiregulin; AR, colorectum cell-derived growth f	84.31
2wph_E		59	Coagulation factor IXA light chain; serine proteas	84.21
2i9a_A		145	Urokinase-type plasminogen activator; growth facto	83.95
1iox_A		50	Betacellulin; EGF-like fold, hormone/growth factor	83.3
1xdt_R		79	Hbegf, heparin-binding epidermal growth factor; co	83.28
3e50_C		50	Protransforming growth factor alpha; IDE, TGF-alph	81.63
1nzi_A		159	Complement C1S component; calcium, innate immunity	81.49
1iox_A		50	Betacellulin; EGF-like fold, hormone/growth factor	81.43
2rnl_A		50	Amphiregulin; AR, colorectum cell-derived growth f	80.73
3e50_C		50	Protransforming growth factor alpha; IDE, TGF-alph	80.52

>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A*	Back alignment and structure

Probab=99.82  E-value=3.7e-24  Score=235.99  Aligned_cols=258  Identities=10%  Similarity=-0.054  Sum_probs=175.9

Q ss_pred             ccccCCCCCcccCCCC---ccCCCCCCCCCCccCCCCCCCCcccCCCCCCCCCCCCCCCCeeeecCCCccccCCCCCccC
Q psy13157        318 QCRDINGSPSCSCLPN---YIGAPPNCRPECVQNSECPHDKACINEKCADPCLGSCGYGAVCTVINHSPICTCPEGFIGD  394 (1434)
Q Consensus       318 ~C~n~~gsy~C~C~~G---y~g~~~~C~~~C~~~~eC~~~~~C~~~~C~~~C~~~C~~~~~C~~~~gsy~C~C~~G~~G~  394 (1434)
                      ++.|..|+|++.+.+|   |+|.  +++..+...+                  .+|.++++|++..++|+|.|++||+|.
T Consensus         5 ~~~n~~Gg~s~~~~pgg~~~~g~--~~~~n~~~~~------------------~~c~ngG~C~~g~~~y~C~Cp~Gf~G~   64 (267)
T 4fbr_A            5 LVQNQWGGSQATWNPGGLWLIGA--RDKQNVVALD------------------IKSDDGGKTLKGTMTYNGEGPIGFRGT   64 (267)
T ss_dssp             EEEEECSSTTSCCEEEEEEECCC--CSSCCEEEEE------------------EECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred             eEeecCCcccCCcCCCCceeecc--ccccccccCC------------------CCcCCCCeecCCCCCeEEeCCCCcccc
Confidence            4567789999999998   5555  5543221111                  247789999999999999999999999


Q ss_pred             CCcccCCCCCCCCCCCCCCCCCCCCCCCeeecceeccCCCcccCCCccCCCccccCCCCCCCcccccCCCCCCCCCCCCC
Q psy13157        395 AFSSCYPKPPEPIEPVIQEDTCNCVPNAECRDGVCLCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCTPGTCG  474 (1434)
Q Consensus       395 ~c~~C~~~~~~~~~~c~~~~~c~C~~~~~C~~~~C~C~~Gy~G~~~~~c~~~C~~~~~C~~~~~C~~~~C~~~C~~~~C~  474 (1434)
                      .|+.       +++++                                     +.               ...|.+.||+
T Consensus        65 ~Ce~-------ni~ec-------------------------------------~~---------------~~~c~s~pC~   85 (267)
T 4fbr_A           65 LSSA-------NNYTV-------------------------------------EN---------------QWGGTSAPWQ   85 (267)
T ss_dssp             ECST-------TEEEE-------------------------------------EE---------------ESSSTTSCEE
T ss_pred             cccc-------ccccc-------------------------------------cc---------------ccCcCCCccc
Confidence            8762       22221                                     11               1224456777


Q ss_pred             CCCEEeccCCceEeeCCCCCcCCCCccccccccCCCCCCCCCCCCCCCCceeeccCCCeeeeCCCCCcCCCCCCcCCCcc
Q psy13157        475 EGAICDVVNHAVSCTCPPGTTGSPFVQCKTIQYEPVYTNPCQPSPCGPNSQCREVNHQAVCSCLPNYFGSPPACRPECTV  554 (1434)
Q Consensus       475 ~~~~C~~~~g~y~C~C~~G~~G~~~~~C~~~~~~~~~~d~C~~~~C~~~g~C~~~~g~y~C~C~~Gy~G~~~~c~~~C~~  554 (1434)
                      ++++|              |+|..   |+.       +++|++.||.++|+|++..++|+|+|++||+|.      .|+.
T Consensus        86 nggtc--------------~~G~~---c~~-------~~eC~s~pC~ngG~C~~~~~sy~C~C~~Gf~G~------~Ce~  135 (267)
T 4fbr_A           86 PGGVW--------------VLGAR---DKQ-------NIVAVSIKSNDGGKTLTGTTTYNGEGPIGFKSE------VTDG  135 (267)
T ss_dssp             EEEEE--------------ECCCC---SSC-------CEEEEEEECSSTTSEEEEEEEETTSCCEEEEEE------ECCC
T ss_pred             CCCee--------------eccCc---ccc-------ccccCCCCCCCCCEEecCCccEEeeCCCCcccc------CCCC
Confidence            76655              45665   765       468888999999999999999999999999998      6776


Q ss_pred             CCCCCCCCcccCCcccCCCCCCCCCCceeeecCCCceeeCCCCCccCCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy13157        555 NSDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPVCSCKPGFTGEPRIRCNKIPPRPPPQEDVPEPVNPCYPSPCGPY  634 (1434)
Q Consensus       555 ~~~C~~~~~C~~~~C~~~C~~~C~~~~~C~~~~g~~~C~C~~Gy~G~~~~~C~~~~~~~~~~~~c~~dideC~~~~C~~~  634 (1434)
                      .+     ++|.+..+-.  ..+|.+.++|              |.|..   |+             .+| .|.+.||.++
T Consensus       136 ~~-----d~C~n~~~c~--s~pC~ngg~c--------------~~G~~---c~-------------~~i-~c~~~~c~ng  177 (267)
T 4fbr_A          136 DT-----YSVENQWGGS--AAPWHSGGVW--------------VLGTR---GK-------------QNV-INVDAKSNDG  177 (267)
T ss_dssp             CE-----EEEEEECSST--TSCCEEEEEE--------------ECCSS---TT-------------SCE-EEEEEECSST
T ss_pred             Cc-----ccccccCCcC--CccccCCcce--------------ecccc---cc-------------ccc-ccCCCCCCCC
Confidence            54     2433321100  1233333333              22443   53             233 3556789999


Q ss_pred             CeeEecCCCceeeCCCCCcCCCCCCccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCeeeccCCCceeeCCC
Q psy13157        635 SQCRDIGGSPSCSCLPNYIGSPPNCRPECVMNSECPSHEASRPPPQEDVPEPVNPCYPSPCGPYSQCRDIGGSPSCSCLP  714 (1434)
Q Consensus       635 ~~C~n~~gsy~C~C~~Gy~g~~~~C~~~C~~~~~C~~~~~~~~~~~~~~~~~ideC~~~~C~~~~~C~n~~gsy~C~C~~  714 (1434)
                      ++|++..++|+|+|++||+|.  .|+                        .+|++|+..++...+.|.+. +.|.+.|+.
T Consensus       178 g~C~dg~~~y~C~Cp~Gf~G~--~c~------------------------~~i~ec~~~~~c~~~~c~~g-G~~~~~C~~  230 (267)
T 4fbr_A          178 GKTLSGTMTYNGEGPIGFRGT--LTS------------------------PDTYTVENQWGGSTAPWNPG-GFWMIGARN  230 (267)
T ss_dssp             TSEEEEEEEETTSCCEEEEEE--EEE------------------------TTEEEEEEECSCTTSCCEEE-EEEECCCCT
T ss_pred             CEeeCCCCCeEEeCCCCcccc--ccc------------------------cccceeccCCCccCCcccCC-CeEEEecCC
Confidence            999999999999999999998  564                        56777654444444555543 456677888


Q ss_pred             CcccCCCCCccCCccCCCCCCcchhcccccCCCCCCCCCCCCeeeecCCcceeeCCCCCccC
Q psy13157        715 NYIGSPPNCRPECVMNSECPSHEACINEKCQDPCPGSCGYNAECKVINHTPICTCPQGFIGD  776 (1434)
Q Consensus       715 Gy~G~~~~C~~~C~~~~eC~~~~~C~~~~C~~~C~~~C~~~~~C~~~~g~y~C~C~~Gy~G~  776 (1434)
                      ||.+.  .++                         .+|.++++|++...+|+|+||+||+|.
T Consensus       231 g~n~~--~c~-------------------------~~c~ngGtC~dg~~sy~CeCp~GF~G~  265 (267)
T 4fbr_A          231 GQNVV--ALN-------------------------VASSDGGKTLAGTMIYNGEGPIGFRAR  265 (267)
T ss_dssp             TCCEE--EEE-------------------------EECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred             CCccc--cCC-------------------------cCCCCCCEeeCCCcceeecCCCCcccc
Confidence            87665  222                         246678999999999999999999985

PyMOL of 4fbr

>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A*	Back alignment and structure

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A	Back alignment and structure

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*	Back alignment and structure

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A	Back alignment and structure

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*	Back alignment and structure

>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens}	Back alignment and structure

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A	Back alignment and structure

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}	Back alignment and structure

>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens}	Back alignment and structure

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}	Back alignment and structure

>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A	Back alignment and structure

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A	Back alignment and structure

>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A	Back alignment and structure

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A	Back alignment and structure

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*	Back alignment and structure

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*	Back alignment and structure

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A	Back alignment and structure

>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B*	Back alignment and structure

>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B*	Back alignment and structure

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A	Back alignment and structure

>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B*	Back alignment and structure

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens}	Back alignment and structure

>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B*	Back alignment and structure

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens}	Back alignment and structure

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A	Back alignment and structure

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B*	Back alignment and structure

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A	Back alignment and structure

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A	Back alignment and structure

>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus}	Back alignment and structure

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A	Back alignment and structure

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B*	Back alignment and structure

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1	Back alignment and structure

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A	Back alignment and structure

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1	Back alignment and structure

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L*	Back alignment and structure

>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus}	Back alignment and structure

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens}	Back alignment and structure

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens}	Back alignment and structure

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L*	Back alignment and structure

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L*	Back alignment and structure

>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ...

Back alignment and structure

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L*	Back alignment and structure

Back alignment and structure

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens}	Back alignment and structure

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L*	Back alignment and structure

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ...	Back alignment and structure

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L*	Back alignment and structure

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A	Back alignment and structure

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ...	Back alignment and structure

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A	Back alignment and structure

>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A	Back alignment and structure

>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A	Back alignment and structure

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens}	Back alignment and structure

>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A	Back alignment and structure

>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A	Back alignment and structure

>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens}	Back alignment and structure

>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A	Back alignment and structure

>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens}	Back alignment and structure

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A	Back alignment and structure

>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens}	Back alignment and structure

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A	Back alignment and structure

>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A	Back alignment and structure

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L	Back alignment and structure

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L	Back alignment and structure

>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens}	Back alignment and structure

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus}	Back alignment and structure

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus}	Back alignment and structure

>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A	Back alignment and structure

>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A	Back alignment and structure

>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A	Back alignment and structure

>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A	Back alignment and structure

>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1	Back alignment and structure

>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1	Back alignment and structure

>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A	Back alignment and structure

>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A	Back alignment and structure

>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A	Back alignment and structure

>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens}	Back alignment and structure

>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A	Back alignment and structure

>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A	Back alignment and structure

>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1	Back alignment and structure

>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}	Back alignment and structure

>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D	Back alignment and structure

>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A	Back alignment and structure

>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A	Back alignment and structure

>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D	Back alignment and structure

>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}	Back alignment and structure

>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1	Back alignment and structure

>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens}	Back alignment and structure

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ...	Back alignment and structure

>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A	Back alignment and structure

>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A	Back alignment and structure

>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C*	Back alignment and structure

>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C*	Back alignment and structure

>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L*	Back alignment and structure

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ...	Back alignment and structure

>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A	Back alignment and structure

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A	Back alignment and structure

>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L*	Back alignment and structure

>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4	Back alignment and structure

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A	Back alignment and structure

>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4	Back alignment and structure

>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A	Back alignment and structure

>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A	Back alignment and structure

>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster}	Back alignment and structure

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1	Back alignment and structure

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1	Back alignment and structure

>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1	Back alignment and structure

>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster}	Back alignment and structure

>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ...	Back alignment and structure

>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L*	Back alignment and structure

>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ...	Back alignment and structure

>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ...	Back alignment and structure

>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ...	Back alignment and structure

>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L*	Back alignment and structure

>4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus}	Back alignment and structure

>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1	Back alignment and structure

>4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus}	Back alignment and structure

>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A*	Back alignment and structure

>2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus}	Back alignment and structure

>2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus}	Back alignment and structure

>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1	Back alignment and structure

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A	Back alignment and structure

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A	Back alignment and structure

>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B*	Back alignment and structure

>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens}	Back alignment and structure

>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B*	Back alignment and structure

>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A*	Back alignment and structure

>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A	Back alignment and structure

>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1	Back alignment and structure

>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A	Back alignment and structure

>1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1	Back alignment and structure

>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A	Back alignment and structure

>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens}	Back alignment and structure

>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A	Back alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

No hit with e-value below 0.005

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Alignment Graph	Length	Definition	Probability
Query		1434
d1emoa1		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.56
d2vj3a1		42	Neurogenic locus notch homolog protein 1, Notch1 {	98.54
d1edmb_		39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	98.53
d1edmb_		39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	98.47
d2c4fl1		37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	98.46
d2vj3a2		39	Neurogenic locus notch homolog protein 1, Notch1 {	98.4
d2vj3a2		39	Neurogenic locus notch homolog protein 1, Notch1 {	98.37
d2vj3a1		42	Neurogenic locus notch homolog protein 1, Notch1 {	98.36
d2c4fl1		37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	98.33
d2vj3a3		35	Neurogenic locus notch homolog protein 1, Notch1 {	98.23
d1emoa1		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.21
d2vj3a3		35	Neurogenic locus notch homolog protein 1, Notch1 {	98.18
d1xkba1		39	Factor X, N-terminal module {Human (Homo sapiens)	98.18
d1xkba1		39	Factor X, N-terminal module {Human (Homo sapiens)	98.17
d1gl4a2		40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	98.09
d1lmja1		44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.05
d1lmja2		42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.85
d1g1ta2		39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	97.84
d1g1sa2		40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	97.84
d1q4ga2		42	Prostaglandin H2 synthase-1, EGF-like module {Shee	97.84
d1g1sa2		40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	97.82
d1g1ta2		39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	97.81
d1uzka1		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.8
d1apqa_		53	Complement protease C1R {Human (Homo sapiens) [Tax	97.8
d1autl1		48	Activated protein c (autoprothrombin IIa) {Human (	97.79
d1tpga1		41	Plasminogen activator (tissue-type), t-PA {Human (	97.77
d1lmja1		44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.75
d1uzka1		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.71
d1cvua2		41	Prostaglandin H2 synthase-1, EGF-like module {Mous	97.69
d1q4ga2		42	Prostaglandin H2 synthase-1, EGF-like module {Shee	97.67
d1autl1		48	Activated protein c (autoprothrombin IIa) {Human (	97.61
d1dx5i3		40	Thrombomodulin, different EGF-like domains {Human	97.6
d1uzka2		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.58
d1cvua2		41	Prostaglandin H2 synthase-1, EGF-like module {Mous	97.55
d1lmja2		42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.53
d1gl4a2		40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	97.51
d1tpga1		41	Plasminogen activator (tissue-type), t-PA {Human (	97.49
d1uzka2		43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.33
d1apqa_		53	Complement protease C1R {Human (Homo sapiens) [Tax	97.27
d1szba2		45	Mannose-binding protein associated serine protease	97.16
d1dx5i3		40	Thrombomodulin, different EGF-like domains {Human	97.15
d1i0ua2		41	Low density lipoprotein (LDL) receptor, different	97.12
d1i0ua2		41	Low density lipoprotein (LDL) receptor, different	97.09
d1haea_		63	Heregulin-alpha, EGF-like domain {Human (Homo sapi	96.94
d1haea_		63	Heregulin-alpha, EGF-like domain {Human (Homo sapi	96.94
d1szba2		45	Mannose-binding protein associated serine protease	96.88
d1nt0a3		45	Mannose-binding protein associated serine protease	96.86
d1emoa2		39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	96.8
d1nt0a3		45	Mannose-binding protein associated serine protease	96.77
d3egfa_		53	Epidermal growth factor, EGF {Mouse (Mus musculus)	96.61
d3egfa_		53	Epidermal growth factor, EGF {Mouse (Mus musculus)	96.51
d1nqlb_		48	Epidermal growth factor, EGF {Human (Homo sapiens)	96.38
d3bpse1		40	Low density lipoprotein (LDL) receptor, different	96.18
d1nzia2		42	Complement C1S component {Human (Homo sapiens) [Ta	96.14
d1nqlb_		48	Epidermal growth factor, EGF {Human (Homo sapiens)	96.12
d1emoa2		39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	95.85
d3bpse1		40	Low density lipoprotein (LDL) receptor, different	95.48
d1nzia2		42	Complement C1S component {Human (Homo sapiens) [Ta	95.42
d2i9aa1		40	Plasminogen activator (urokinase-type) {Human (Hom	93.61
d2i9aa1		40	Plasminogen activator (urokinase-type) {Human (Hom	93.39
d1k36a_		46	Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI	91.54
d2p3ua1		51	Factor X, N-terminal module {Human (Homo sapiens)	91.13
d1autl2		50	Activated protein c (autoprothrombin IIa) {Human (	91.04
d1ioxa_		50	Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]	90.43
d1k36a_		46	Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI	90.1
d1kigl_		51	Factor X, N-terminal module {Cow (Bos taurus) [Tax	89.32
d1kigl_		51	Factor X, N-terminal module {Cow (Bos taurus) [Tax	88.81
d1l3ya_		41	Integrin beta EGF-like domains {Human (Homo sapien	88.47
d1ioxa_		50	Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]	88.2
d1moxc_		49	Transforming growth factor alpha {Human (Homo sapi	87.88
d1autl2		50	Activated protein c (autoprothrombin IIa) {Human (	86.94
d1kloa1		55	Laminin gamma1 chain {Mouse (Mus musculus) [TaxId:	86.64
d1l3ya_		41	Integrin beta EGF-like domains {Human (Homo sapien	86.14
d1oiga_		26	Dumpy {Fruit fly (Drosophila melanogaster) [TaxId:	85.81
d2p3ua1		51	Factor X, N-terminal module {Human (Homo sapiens)	85.34
d1moxc_		49	Transforming growth factor alpha {Human (Homo sapi	84.88
d1jv2b4		31	Integrin beta EGF-like domains {Human (Homo sapien	80.99
d1kloa1		55	Laminin gamma1 chain {Mouse (Mus musculus) [TaxId:	80.6

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=1e-08  Score=78.65  Aligned_cols=42  Identities=21%  Similarity=0.500  Sum_probs=36.8

Q ss_pred             CCCCCCCCCCCCCCCCeEeecCCcceeEcCCCcccCCCCCcc
Q psy13157       1206 PEPVNPCYPSPCGLYSECRNVNGAPSCSCLINYIGSPPNCRP 1247 (1434)
Q Consensus      1206 ~~dineC~~~~C~~~~~C~~~~gs~~C~C~~Gy~G~~~~C~~ 1247 (1434)
                      |+|||||+..++..+++|+|++|||+|.|++||++++.+|+|
T Consensus         2 CvDidEC~~~~~~~~~~C~Nt~Gsy~C~C~~Gy~~~g~~C~D   43 (43)
T d1emoa1           2 AVDMDECKEPDVCKHGQCINTDGSYRCECPFGYILAGNECVD   43 (43)
T ss_dssp             CCCCCSSSSTTSCSSSCCCCCSSCCCCCCCTTEEESSSCEEE
T ss_pred             CcceeccCCcCCCCCCEeECCCCCeEeECCCCcccCCCcccC
Confidence            589999987777778999999999999999999988777753

PyMOL of d1emoa1

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	Back information, alignment and structure

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	Back information, alignment and structure

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]}	Back information, alignment and structure

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]}	Back information, alignment and structure

>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]}	Back information, alignment and structure

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]}	Back information, alignment and structure

>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]}	Back information, alignment and structure

>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]}	Back information, alignment and structure

>d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure

>d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1oiga_ g.3.18.1 (A:) Dumpy {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}	Back information, alignment and structure

>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1jv2b4 g.3.11.6 (B:532-562) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}	Back information, alignment and structure

>d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]}	Back information, alignment and structure